Seven Fleet Capital Management
Latest statistics and disclosures from Seven Fleet Capital Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002092021
Tip: Access up to 7 years of quarterly data
Positions held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Seven Fleet Capital Management
Seven Fleet Capital Management holds 85 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cg Oncology (CGON) | 47.8 | $63M | 1.5M | 41.52 |
|
|
| Soleno Therapeutics (SLNO) | 4.6 | $6.0M | 130k | 46.30 |
|
|
| Revolution Medicines (RVMD) | 4.0 | $5.2M | 66k | 79.65 |
|
|
| Liquidia Corporation Com New (LQDA) | 2.4 | $3.1M | 91k | 34.49 |
|
|
| Compass Therapeutics (CMPX) | 2.3 | $3.1M | 569k | 5.37 |
|
|
| Exelixis (EXEL) | 2.3 | $3.0M | 69k | 43.83 |
|
|
| Axsome Therapeutics (AXSM) | 1.8 | $2.4M | 13k | 182.64 |
|
|
| Tyra Biosciences (TYRA) | 1.6 | $2.1M | 80k | 26.29 |
|
|
| Cogent Biosciences (COGT) | 1.5 | $1.9M | 54k | 35.52 |
|
|
| Tango Therapeutics (TNGX) | 1.4 | $1.9M | 215k | 8.86 |
|
|
| Xencor (XNCR) | 1.3 | $1.7M | 110k | 15.31 |
|
|
| Pharvaris N V (PHVS) | 1.2 | $1.5M | 55k | 27.75 |
|
|
| Terns Pharmaceuticals (TERN) | 1.1 | $1.5M | 37k | 40.40 |
|
|
| Belite Bio Sponsored Ads (BLTE) | 1.1 | $1.5M | 9.2k | 159.96 |
|
|
| Dyne Therapeutics (DYN) | 1.0 | $1.4M | 70k | 19.56 |
|
|
| Nuvalent Inc-a (NUVL) | 1.0 | $1.3M | 13k | 100.59 |
|
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $1.2M | 5.7k | 213.24 |
|
|
| Amicus Therapeutics (FOLD) | 0.9 | $1.2M | 83k | 14.24 |
|
|
| Vaxcyte (PCVX) | 0.9 | $1.2M | 25k | 46.14 |
|
|
| Avalo Therapeutics Com New (AVTX) | 0.9 | $1.2M | 63k | 18.16 |
|
|
| Inhibikase Therapeutics Com New (IKT) | 0.8 | $1.1M | 534k | 2.05 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $1.1M | 1.9k | 582.34 |
|
|
| Geron Corporation (GERN) | 0.8 | $1.0M | 778k | 1.32 |
|
|
| Krystal Biotech (KRYS) | 0.8 | $986k | 4.0k | 246.54 |
|
|
| Athira Pharma | 0.7 | $969k | 128k | 7.57 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.7 | $920k | 167k | 5.50 |
|
|
| Silence Therapeutics Ads (SLN) | 0.7 | $897k | 148k | 6.08 |
|
|
| Zura Bio Class A Ord Shs (ZURA) | 0.7 | $873k | 167k | 5.24 |
|
|
| Agios Pharmaceuticals (AGIO) | 0.7 | $864k | 32k | 27.22 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 0.6 | $796k | 2.7k | 294.74 |
|
|
| Celcuity (CELC) | 0.6 | $783k | 7.8k | 99.74 |
|
|
| Kalvista Pharmaceuticals (KALV) | 0.6 | $782k | 48k | 16.15 |
|
|
| Palisade Bio (PALI) | 0.6 | $770k | 328k | 2.35 |
|
|
| Relmada Therapeutics (RLMD) | 0.6 | $744k | 154k | 4.83 |
|
|
| Protagonist Therapeutics (PTGX) | 0.5 | $699k | 8.0k | 87.34 |
|
|
| Cidara Therapeutics Com New (CDTX) | 0.5 | $668k | 3.0k | 220.89 |
|
|
| Cytokinetics Com New (CYTK) | 0.5 | $657k | 10k | 63.54 |
|
|
| Nektar Therapeutics Com New (NKTR) | 0.5 | $634k | 15k | 42.28 |
|
|
| United Therapeutics Corporation (UTHR) | 0.5 | $633k | 130k | 4.87 |
|
|
| Relay Therapeutics (RLAY) | 0.5 | $618k | 73k | 8.46 |
|
|
| Dianthus Therapeutics (DNTH) | 0.5 | $604k | 15k | 41.21 |
|
|
| Mbx Biosciences (MBX) | 0.4 | $574k | 18k | 31.54 |
|
|
| Mineralys Therapeutics (MLYS) | 0.4 | $553k | 15k | 36.29 |
|
|
| Evolus (EOLS) | 0.4 | $545k | 82k | 6.65 |
|
|
| Zymeworks Del (ZYME) | 0.4 | $542k | 21k | 26.33 |
|
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.4 | $462k | 57k | 8.14 |
|
|
| Miragen Therapeutics (VRDN) | 0.3 | $456k | 15k | 31.12 |
|
|
| Prothena Corp SHS (PRTA) | 0.3 | $414k | 43k | 9.55 |
|
|
| Nurix Therapeutics (NRIX) | 0.3 | $379k | 20k | 18.97 |
|
|
| Savara (SVRA) | 0.3 | $379k | 63k | 6.03 |
|
|
| Tarsus Pharmaceuticals (TARS) | 0.3 | $369k | 4.5k | 81.88 |
|
|
| Pliant Therapeutics (PLRX) | 0.3 | $337k | 277k | 1.22 |
|
|
| Aclaris Therapeutics (ACRS) | 0.2 | $323k | 107k | 3.01 |
|
|
| Septerna (SEPN) | 0.2 | $319k | 11k | 27.88 |
|
|
| Eliem Therapeutics (CLYM) | 0.2 | $306k | 76k | 4.00 |
|
|
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $276k | 40k | 6.90 |
|
|
| Entera Bio SHS (ENTX) | 0.2 | $263k | 135k | 1.94 |
|
|
| Viking Therapeutics (VKTX) | 0.2 | $211k | 6.0k | 35.18 |
|
|
| Uniqure Nv SHS (QURE) | 0.2 | $209k | 8.7k | 23.93 |
|
|
| Cytomx Therapeutics (CTMX) | 0.2 | $208k | 49k | 4.26 |
|
|
| Ocular Therapeutix (OCUL) | 0.2 | $208k | 17k | 12.14 |
|
|
| Enliven Therapeutics (ELVN) | 0.1 | $180k | 12k | 15.40 |
|
|
| Oruka Therapeutics (ORKA) | 0.1 | $159k | 5.2k | 30.31 |
|
|
| Assembly Biosciences Com New (ASMB) | 0.1 | $147k | 4.3k | 34.01 |
|
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.1 | $140k | 4.0k | 35.08 |
|
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $140k | 12k | 12.08 |
|
|
| Apogee Therapeutics (APGE) | 0.1 | $136k | 1.8k | 75.48 |
|
|
| Alx Oncology Hldgs (ALXO) | 0.1 | $133k | 118k | 1.13 |
|
|
| Verastem Com New (VSTM) | 0.1 | $117k | 15k | 7.72 |
|
|
| Regencell Bioscience Hldgs L Ordinary Shares (RGC) | 0.1 | $92k | 4.4k | 21.00 |
|
|
| Trevi Therapeutics (TRVI) | 0.1 | $89k | 7.1k | 12.52 |
|
|
| Immunic (IMUX) | 0.1 | $83k | 155k | 0.53 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.1 | $79k | 64k | 1.25 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.0 | $63k | 4.0k | 15.68 |
|
|
| Traws Pharma Com New (TRAW) | 0.0 | $56k | 49k | 1.13 |
|
|
| Astria Therapeutics | 0.0 | $52k | 4.0k | 13.09 |
|
|
| Edgewise Therapeutics (EWTX) | 0.0 | $50k | 2.0k | 24.82 |
|
|
| Vistagen Therapeutics Ord (VTGN) | 0.0 | $42k | 63k | 0.66 |
|
|
| Enanta Pharmaceuticals (ENTA) | 0.0 | $36k | 2.3k | 15.77 |
|
|
| Cullinan Oncology (CGEM) | 0.0 | $31k | 3.0k | 10.35 |
|
|
| Generation Bio Com New (GBIO) | 0.0 | $31k | 5.4k | 5.68 |
|
|
| Beam Therapeutics (BEAM) | 0.0 | $9.3k | 337.00 | 27.72 |
|
|
| Eledon Pharmaceuticals (ELDN) | 0.0 | $9.1k | 6.0k | 1.51 |
|
|
| Abivax Sa Sponsored Ads (ABVX) | 0.0 | $1.6k | 12.00 | 134.83 |
|
|
| Vir Biotechnology (VIR) | 0.0 | $1.2k | 200.00 | 6.03 |
|
Past Filings by Seven Fleet Capital Management
SEC 13F filings are viewable for Seven Fleet Capital Management going back to 2025
- Seven Fleet Capital Management 2025 Q4 filed Feb. 26, 2026